Huang James
- SEC CIK
- 0001573160
In the past year, 2 open-market purchase filings worth $4.37M and 2 sale filings worth $3.65M.
Current role at each company
- CNTB Connect Biopharma Holdings LtdDirectoras of Jun 2, 2026
- ATRA Atara Biotherapeutics, Inc.Director, 10% Owneras of May 11, 2026
- TCRT Alaunos Therapeutics, Inc.Directoras of Jun 8, 2023
- Orion Biotech Opportunities Corp.Chief Executive Officeras of May 18, 2023
- WINT Windtree Therapeutics IncDirectoras of Feb 23, 2023
Show 1 more company
- CASI CASI Pharmaceuticals, Inc (DE)Directoras of Sep 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $4.37M
- 2 filings
- Sold
- $3.65M
- 2 filings
- Net
- +$720.0K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Huang James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CNTB Connect Biopharma Holdings Ltd
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | May 29 | 4 days | Huang JamesDirector | PPurchase | +150.0K | $2.48 | +$372.0K | +1.1%13.3M after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Huang JamesDirector | PPurchase | +1.16M | $3.45 | +$4.00M | +9.7%13.2M after |
ATRA Atara Biotherapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing)6:45 PM ET | May 7 | 4 days | Huang James and 1 otherDirector, 10% Owner | SSale | −313.4K | $10.10 | −$3.17M | −23.7%1.01M after | |
| Jan 14, 2026 (view filing)9:16 PM ET | Jan 12 | 2 days | Huang James and 1 otherDirector, 10% Owner | SSale | −80.6K | $6.07 | −$489.0K | −5.7%1.32M after | |
| Aug 19, 2025 (view filing)8:15 PM ET | Aug 15 | 4 days | Huang James and 1 otherDirector, 10% Owner | PPurchase | +55.0K | $12.19 | +$670.4K | +4.1%1.41M after | |
| Jul 21, 2025 (view filing)9:00 AM ET | Jul 17 | 4 days | Huang James and 1 otherDirector, 10% Owner | PPurchase | +19.3K | $9.64 | +$186.4K | +1.5%1.35M after |
CASI CASI Pharmaceuticals, Inc (DE)
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2022 (view filing) | Sep 6-8 | 2 days | Huang JamesDirector | PPurchase | +55.6K | $4.13 | +$229.5K | +17.6%371.5K after | 3 lots |
| Sep 2, 2022 (view filing) | Aug 31-Sep 2 | 2 days | Huang JamesDirector | PPurchase | +37.2K | $3.74 | +$139.1K | +13.3%315.9K after | 3 lots |
| Aug 26, 2022 (view filing) | Aug 24-26 | 2 days | Huang JamesDirector | PPurchase | +44.5K | $3.75 | +$167.0K | +19.0%278.7K after | 2 lots |
| Aug 23, 2022 (view filing) | Aug 19-23 | 4 days | Huang JamesDirector | PPurchase | +234.2K | $3.33 | +$779.5K | New position234.2K after | 3 lots |
WINT Windtree Therapeutics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 (view filing) | Oct 19 | Same day | Huang JamesDirector | PPurchase | +50.0K | $1.90 | +$95.0K | +20.7%291.3K after |
TCRT Alaunos Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Huang JamesDirector | PPurchase | +100.0K | $1.71 | +$171.0K | +1,200.0%108.3K after |